Category : Search result: pharmaceutical prices Canada


Montreal Real Estate Defies Condo Slump in October

Discover how Montreal's housing market maintained robust momentum in October 2023, with single-family homes leading growth despite declining condominium sales across the metropolitan area.

Trump Obesity Drug Deal Boosts Pharma Stocks

Major pharmaceutical giants Novo Nordisk and Eli Lilly experience significant stock surges as former President Donald Trump considers a groundbreaking obesity drug partnership, potentially revolutionizing weight loss treatment accessibility.

Canadian Food Prices Skyrocket: Crisis Deepens

Canadian families face unprecedented pressure as food prices continue their relentless climb. Discover which staples are hitting hardest and what experts say about relief.

Chocolate Profits Melt Under Cocoa Price Surge

Global chocolate giant Barry Callebaut reports significant profit decline as cocoa prices reach unprecedented highs, forcing industry-wide price adjustments and innovation.

Budget 2024 Misses Grocery Affordability

Despite soaring food costs hurting Canadian families, the latest federal budget offers little relief for grocery bills. Analysis reveals why this budget fails to address the kitchen table economics that matter most to voters.

Chicken Prices to Rise 20-25% in Canada

Canadian consumers face significant grocery bill increases as experts predict chicken prices will jump 20-25% over the next several months due to production costs and supply chain pressures.

Fraser Valley Housing Rebounds in October

Fraser Valley's housing market experienced a significant October revival with sales jumping 23% from September, though activity still trails typical seasonal patterns. Inventory grows as prices show mixed trends across property types.

Pharma Veteran Dr. Andreas Wallnofer Joins Optigo Board

Optigo Biotherapeutics strengthens leadership with renowned pharmaceutical expert Dr. Andreas Wallnofer joining its Board of Directors as the company progresses toward Investigational New Drug (IND) enabling studies.

Top FDA Drug Official Resigns Amid Federal Probe

The FDA's principal deputy commissioner, Dr. Namandjé Bumpus, resigns following federal probe into undisclosed concerns about her conduct, marking significant leadership shakeup.

Kimberly-Clark Buys Tylenol Maker in $48.7B Deal

In a landmark move reshaping the consumer healthcare landscape, Kimberly-Clark announces its acquisition of Kenvue, the company behind Tylenol and other household brands, in a staggering US$48.7 billion transaction that creates a new industry powerhouse.

Blood Pressure Medication Recall Over Cancer Risk

Health Canada issues urgent recall for specific blood pressure medications containing potentially carcinogenic nitrosamine impurity. Learn which lots are affected and what steps to take.

Boehringer Ingelheim Licenses Novel Autoimmune Treatment

Global pharmaceutical leader Boehringer Ingelheim secures exclusive license from Kyowa Kirin to develop innovative autoimmune disease treatment, targeting conditions like lupus and rheumatoid arthritis with novel therapeutic approach.

Halloween Candy Prices Soar: Here's Why

Discover the surprising factors driving up Halloween candy prices in Canada, from climate change to supply chain issues, and learn how to save on your spooky treats.

Page 4 of 4